About PURE Bioscience
PURE Bioscience is a publicly listed company based in El Cajon (United States) founded in 1992. Antimicrobial products are manufactured and distributed by PURE Bioscience. The company has 12 employees. PURE Bioscience offers products and services including PURE Hard Surface and PURE Control. Its focus areas include Food and Agriculture, Food Processing and Diversified.
Company details
PURE Bioscience was founded in 1992 in El Cajon, United States, within the antimicrobial sector. Products based on silver ion technology are developed and produced for applications in healthcare, food safety, and surface disinfection. Operations center on research, manufacturing, and supply chain management, with distribution handled via the domain purebio.com. The company maintains a focus on regulatory compliance and market needs in North America.
- Headquarters El Cajon, United States
- Employees 12
- Stage Public
- SectorsConsumer
- Email••••••••
- Phone•••• ••••
- Website purebio.com
- Social LinkedIn Facebook Instagram
- Legal Name Pure Bioscience
- Annual Revenue$2.2 M (USD)12.18as on Jul 31, 2025
- Net Profit-$2.4 M (USD)28.39as on Jul 31, 2025
- EBITDA-$2.27 M (USD)23.9as on Jul 31, 2025
- Latest Funding Round$1.5M (USD), Post-IPO
Aug 2018
- Employee Count12
Products & Services of PURE Bioscience
PURE Bioscience offers a comprehensive portfolio of products and services, including PURE Hard Surface and PURE Control.
A powerful disinfectant is designed for comprehensive environmental sanitation in food operations, where it is utilized to remove fouling and eliminate bacteria without harsh chemicals.
An FDA-approved aid is used in poultry and produce processing, where it is applied to reduce pathogens like Salmonella and Listeria without affecting product quality.
Funding Insights of PURE Bioscience
- Total Rounds 20
- Last Round Post-IPO — $1.5M
- First Round $6.5M
(Mar 2006)
Latest 10 of 20 funding rounds of PURE Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $1.5M | Post-IPO | – | – | – |
| Jul 2018 | $500,000 | Debt – Conventional | – | – | – |
| Oct 2017 | $2.8M | Post-IPO | – | – | – |
| Feb 2017 | $337,000 | Post-IPO | – | – | – |
| Dec 2016 | $1M | Post-IPO | – | – | – |
| Dec 2015 | $2M | Post-IPO | – | – | – |
| Oct 2015 | $6M | Post-IPO | – | – | – |
| Sep 2014 | $9.95M | Post-IPO | – | – | – |
| Mar 2014 | $1.13M | Post-IPO | – | – | – |
| Dec 2013 | $1.18M | Post-IPO | – | – | – |
People of PURE Bioscience
14 people are tracked at PURE Bioscience (5 in leadership, 6 in board & advisors, 3 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Tim Steffensmeier | Vice President Of Sales And Marketing | Leadership |
Dolana Blount | Director Of Regulatory Affairs/director Of Microbiology/life Sciences | Leadership |
Mike Klem | Director Of Distribution Sales | Leadership |
Mark Elliott | VP, Finance | Leadership |
Robert Barlett | CEO & President | Leadership |
Tom Y. Lee | Board Member | Board & advisors |
Martin Wiedmann | Scientific Advisor | Board & advisors |
Scott Harris | Scientific Advisor | Board & advisors |
David M. Rendall | Board Member | Board & advisors |
Ivan Chen | Chairman | Board & advisors |
Bernard Blotner | Board Member | Board & advisors |
Tom Myers | EVP, Technology & Development | Team |
Zhinong Yan | EVP Science And Businesse Development | Team |
Ashley Gumienny | Accounts Receivable And Accounts Payable Manager | Team |
Complete people profiles for PURE Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PURE Bioscience
PURE Bioscience is a publicly listed company on the OTC with ticker symbol PURE in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Aug 1996
- Listed onNASDAQ: PURE
- Listed entityPURE Bioscience
- Exchange sectorProcess industries
- ISINUS74621T2096
- Share price$0.08 (-7.16% on the day) · 2026-10-13
- Market capitalisation$9.8M
- EPS (diluted, trailing year)$-0.02
- Volume (last session)34,455
Financials of PURE Bioscience
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.2M | -$2.4M | -$2.3M |
| 2024 | $2.0M | -$3.4M | -$3.0M |
| 2023 | $1.9M | -$4.0M | -$3.5M |
| 2022 | $1.9M | -$3.5M | -$3.2M |
| 2021 | $3.9M | -$2.3M | -$2.1M |
Detailed financial statements for PURE Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PURE Bioscience
4 dated milestones of PURE Bioscience across 26 years, from founding to its latest funding, stage changes and deals.
- Founded PURE Bioscience is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $6.5M.
- Funding Latest funding round, Post-IPO, of $1.5M.
Web traffic of PURE Bioscience
The website of PURE Bioscience (purebio.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 31.8% vs previous month
Websites whose visitors overlap most with PURE Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| protherainc.com | 100% | View details | |||
puregreen24.com | puregreen24.com | 88% | #3,510,092 | – | |
| astec-bio.com | 59% | #1,466,086 | View details |
Top companies in Food Processing
3 companies that operate in the same segment as PURE Bioscience (Food Processing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering refrigerated pet food | 2006 | Secaucus, New Jersey, United States | USD 54 M | USD 1.1 B | 1,300 | |
Coffee, tea, and extract beverage solutions are provided globally. | 2009 | North Little Rock, Arkansas, United States | USD 17 M | USD 1.19 B | 1,410 | |
Multi-category food products are produced and distributed globally. | 1866 | Minneapolis, Minnesota, United States | USD 18.42 B | 33,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pure Bioscience
Complete news archive for PURE Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PURE Bioscience
PURE Bioscience was founded in 1992 and raised its 1st funding round 14 years after it was founded.
PURE Bioscience is headquartered in El Cajon, United States. It is registered at El Cajon, California, United States.
PURE Bioscience has 12 employees.
Annual revenue of PURE Bioscience is $2.2M as on Jul 31, 2025.
PURE Bioscience was founded in 1992 in El Cajon, United States, within the antimicrobial sector. Products based on silver ion technology are developed and produced for applications in healthcare, food safety, and surface disinfection. Operations center on research, manufacturing, and supply chain management, with distribution handled via the domain purebio.com. The company maintains a focus on regulatory compliance and market needs in North America.
PURE Bioscience offers PURE Hard Surface and PURE Control.
Yes, PURE Bioscience is publicly traded on OTC under the ticker symbol PURE.
PURE Bioscience operates through Pure Bioscience.